Annual CFO:
-$95.21M+$61.11M(+39.09%)Summary
- As of today, ADPT annual cash from operations is -$95.21 million, with the most recent change of +$61.11 million (+39.09%) on December 31, 2024.
- During the last 3 years, ADPT annual cash from operations has risen by +$97.52 million (+50.60%).
- ADPT annual cash from operations is now -146.35% below its all-time high of $205.40 million, reached on December 31, 2019.
Performance
ADPT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$7.13M+$5.30M(+42.66%)Summary
- As of today, ADPT quarterly cash from operations is -$7.13 million, with the most recent change of +$5.30 million (+42.66%) on September 30, 2025.
- Over the past year, ADPT quarterly cash from operations has increased by +$19.94 million (+73.67%).
- ADPT quarterly cash from operations is now -102.56% below its all-time high of $278.30 million, reached on March 31, 2019.
Performance
ADPT Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$60.53M+$19.94M(+24.78%)Summary
- As of today, ADPT TTM cash from operations is -$60.53 million, with the most recent change of +$19.94 million (+24.78%) on September 30, 2025.
- Over the past year, ADPT TTM cash from operations has increased by +$49.12 million (+44.80%).
- ADPT TTM cash from operations is now -121.75% below its all-time high of $278.30 million, reached on March 31, 2019.
Performance
ADPT TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ADPT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +39.1% | +73.7% | +44.8% |
| 3Y3 Years | +50.6% | +83.2% | +70.9% |
| 5Y5 Years | -146.3% | +84.9% | +55.7% |
ADPT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +50.6% | at high | +88.0% | at high | +70.9% |
| 5Y | 5-Year | -146.3% | +50.6% | at high | +88.9% | at high | +71.0% |
| All-Time | All-Time | -146.3% | +50.6% | -102.6% | +88.9% | -121.8% | +71.0% |
ADPT Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$7.13M(+42.7%) | -$60.53M(+24.8%) |
| Jun 2025 | - | -$12.43M(+56.4%) | -$80.47M(+5.7%) |
| Mar 2025 | - | -$28.48M(-128.0%) | -$85.34M(+10.4%) |
| Dec 2024 | -$95.21M(+39.1%) | -$12.49M(+53.8%) | -$95.21M(+13.2%) |
| Sep 2024 | - | -$27.07M(-56.4%) | -$109.65M(+15.2%) |
| Jun 2024 | - | -$17.30M(+54.9%) | -$129.27M(+4.6%) |
| Mar 2024 | - | -$38.35M(-42.4%) | -$135.53M(+13.3%) |
| Dec 2023 | -$156.32M(+15.0%) | -$26.93M(+42.3%) | -$156.32M(+1.9%) |
| Sep 2023 | - | -$46.68M(-98.2%) | -$159.41M(-2.8%) |
| Jun 2023 | - | -$23.56M(+60.2%) | -$155.13M(+13.2%) |
| Mar 2023 | - | -$59.15M(-97.0%) | -$178.64M(+2.9%) |
| Dec 2022 | -$183.94M(+4.6%) | -$30.02M(+29.2%) | -$183.94M(+11.5%) |
| Sep 2022 | - | -$42.41M(+9.9%) | -$207.75M(+0.5%) |
| Jun 2022 | - | -$47.06M(+27.0%) | -$208.79M(-5.0%) |
| Mar 2022 | - | -$64.45M(-19.7%) | -$198.94M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$192.73M(-28.8%) | -$53.83M(-23.9%) | -$192.73M(-7.8%) |
| Sep 2021 | - | -$43.44M(-16.7%) | -$178.75M(+2.0%) |
| Jun 2021 | - | -$37.21M(+36.1%) | -$182.46M(-3.5%) |
| Mar 2021 | - | -$58.24M(-46.2%) | -$176.32M(-17.8%) |
| Dec 2020 | -$149.68M(-172.9%) | -$39.84M(+15.5%) | -$149.68M(-9.6%) |
| Sep 2020 | - | -$47.16M(-51.7%) | -$136.63M(-14.2%) |
| Jun 2020 | - | -$31.08M(+1.7%) | -$119.61M(-14.5%) |
| Mar 2020 | - | -$31.61M(-18.0%) | -$104.50M(-150.9%) |
| Dec 2019 | $205.40M(+736.7%) | -$26.79M(+11.1%) | $205.40M(-11.5%) |
| Sep 2019 | - | -$30.14M(-88.7%) | $232.19M(-11.5%) |
| Jun 2019 | - | -$15.97M(-105.7%) | $262.33M(-5.7%) |
| Mar 2019 | - | $278.30M(+4664.6%) | $278.30M(+4664.6%) |
| Dec 2018 | -$32.26M(+7.5%) | - | - |
| Mar 2018 | - | -$6.10M | -$6.10M |
| Dec 2017 | -$34.86M | - | - |
FAQ
- What is Adaptive Biotechnologies Corporation annual cash from operations?
- What is the all-time high annual cash from operations for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation annual cash from operations year-on-year change?
- What is Adaptive Biotechnologies Corporation quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation quarterly cash from operations year-on-year change?
- What is Adaptive Biotechnologies Corporation TTM cash from operations?
- What is the all-time high TTM cash from operations for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation TTM cash from operations year-on-year change?
What is Adaptive Biotechnologies Corporation annual cash from operations?
The current annual cash from operations of ADPT is -$95.21M
What is the all-time high annual cash from operations for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high annual cash from operations is $205.40M
What is Adaptive Biotechnologies Corporation annual cash from operations year-on-year change?
Over the past year, ADPT annual cash from operations has changed by +$61.11M (+39.09%)
What is Adaptive Biotechnologies Corporation quarterly cash from operations?
The current quarterly cash from operations of ADPT is -$7.13M
What is the all-time high quarterly cash from operations for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high quarterly cash from operations is $278.30M
What is Adaptive Biotechnologies Corporation quarterly cash from operations year-on-year change?
Over the past year, ADPT quarterly cash from operations has changed by +$19.94M (+73.67%)
What is Adaptive Biotechnologies Corporation TTM cash from operations?
The current TTM cash from operations of ADPT is -$60.53M
What is the all-time high TTM cash from operations for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high TTM cash from operations is $278.30M
What is Adaptive Biotechnologies Corporation TTM cash from operations year-on-year change?
Over the past year, ADPT TTM cash from operations has changed by +$49.12M (+44.80%)